Established Cardiovascular Disease First-Line Treatment Decision Framework
A decision framework for first-line management of established cardiovascular disease, covering antiplatelet therapy, statins, ACE inhibitors, beta-blockers, and the evidence for GLP-1 receptor agonists such as semaglutide in patients with cardiovascular disease and excess weight.

